• HOME
  • kspid.or.kr
  • admin

ÇÁ·Î±×·¥

½Ã°£ °­ÁÂ
08:40~ µî·Ï
08:50~09:00 Àλ縻 ȸÀå : ±èÁ¾Çö
I. ÃֽŠ°¡À̵å¶óÀÎ ¸®ºä ÁÂÀå: ÀÌÈ­ÀÇ´ë ±è°æÈ¿
09:00~09:35 ¹«Áõ»ó ¼¼±Õ´¢ÀÇ ÀûÀýÇÑ Ä¡·á (IDSA guideline À§ÁÖ·Î)
Management of asymptomatic bacteriuria
Â÷ÀÇ´ë ÀÌÅÃÁø
9:35~10:10 ½Å»ý¾Æ Á¶¹ß¼º ÆÐÇ÷ÁõÀÇ ÀûÀýÇÑ Ä¡·á (AAP guidelineÀ§ÁÖ·Î)
Management of neonatal early-onset sepsis
ºÎ»êÀÇ´ë ¹Ú¼öÀº
10:10~10:45 ¿Ü·¡¿¡¼­ ÁÖ»ç Ç×»ýÁ¦ÀÇ ÀûÀýÇÑ »ç¿ë (IDSA guideline À§ÁÖ·Î)
Management of outpatient parenteral antimicrobial therapy
ÇÑÀϺ´¿ø ÀÌÁø
10:45~11:05 Q&A
II. ¹é½ÅÀ¸·Î ¿¹¹æ °¡´ÉÇÑ Áúȯ ÁÂÀå: °¡Å縯ÀÇ´ë ±èÁ¾Çö
11:05~11:45 MMR ¹é½Å(È«¿ª°ú dzÁø Áß½ÉÀ¸·Î)
MMR vaccine (focused on measles and rubella)
Ãæ³²ÀÇ´ë Á¶Àº¿µ
11:45~12:25 ¹éÀÏÇØ ¹é½Å
Pertussis vaccine

¼­¿ïÀÇ´ë ÃÖÀºÈ­

12:25~13:30 Á¡½É½Ã°£
III. °¨¿°°ü¸® "To screen or Not to screen?" (* Çʼö°ú¸ñ) ÁÂÀå : ¼­¿ïÀÇ´ë ÃÖÀºÈ­
13:30~14:05 Debate on Active surveillance for CRE/CPE ÇѸ²ÀÇ´ë ÃÖ¼öÇÑ
14:05~14:40 Debate on Active surveillance for MRSA/VRE °¡Å縯ÀÇ´ë ±è±âȯ
14:40~15:15 Practical approaches to Clostridioides difficile prevention in neonate and children ÀüºÏÀÇ´ë Á¶´ë¼±
15:15~15:35 Q&A
IV. ÃֽŠ³í¹® ¸®ºä ÁøÇà: ±³À°¿¬¼öÀÌ»ç
15:35~16:15 ÃֽŠ¹é½Å °ü·Ã ³í¹® ¸®ºä (ÀÎÇ÷翣ÀÚ ¹é½Å À§ÁÖ·Î) °¡Å縯ÀÇ´ë °­Çö¹Ì
16:15~16:25 Çмú³í¹®»ó ¼ö¿©/ 2019 ºÐ°úÀü¹®ÀÇ ÀÚ°ÝÁõ ¼ö¿© ȸÀå: ±èÁ¾Çö
16:25~16:35 Æóȸ»ç ºÎȸÀå: ÃÖÀºÈ­